Perampanel + Perampanel

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Healthy Participants

Conditions

Healthy Participants

Trial Timeline

Nov 8, 2017 → Feb 16, 2018

NCT ID

NCT03376997

About Perampanel + Perampanel

Perampanel + Perampanel is a phase 1 stage product being developed by Eisai for Healthy Participants. The current trial status is completed. This product is registered under clinical trial identifier NCT03376997. Target conditions include Healthy Participants.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Participants were approved

Approved (20) Terminated (1) Active (0)

✅mRNA-1273.712ModernaApproved

✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved

✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved

✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved

✅Perampanel 6 MGEisaiApproved

✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved

✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (8)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04202159	Pre-clinical	Completed	Jan 21, 2020	Mar 31, 2023	Seizures
NCT03754582	Phase 2	Completed	Nov 27, 2018	Dec 10, 2019	Epilepsy
NCT03399734	Phase 1	Completed	Dec 18, 2017	Mar 9, 2018	Healthy Participants
NCT03376997	Phase 1	Completed	Nov 8, 2017	Feb 16, 2018	Healthy Participants
NCT02020486	Phase 1	Completed	Dec 1, 2013	Mar 1, 2014	Healthy
NCT01396577	Phase 1	Completed	Dec 1, 2010	Apr 1, 2011	Healthy
NCT01396590	Phase 1	Completed	Dec 1, 2010	Mar 1, 2011	Healthy
NCT01240187	Phase 1	Completed	Jun 1, 2010	Sep 1, 2010	Partial Onset Epilepsy

Competing Products

20 competing products in Healthy Participants

See all competitors

Product	Company	Stage	Hype Score
Use of Wearable Digital Sensors After mRNA Vaccination in Adults	Moderna	Preclinical	0
mRNA-0184	Moderna	Phase 1	0
mRNA-6231	Moderna	Phase 1	0
Letrozole	Dr. Reddy's Laboratories	Phase 1	26
Isotretinoin	Dr. Reddy's Laboratories	Phase 1	26
Fexofenadine	Dr. Reddy's Laboratories	Phase 1	26
Sertraline	Dr. Reddy's Laboratories	Phase 1	26
Nizatidine + Axid	Dr. Reddy's Laboratories	Phase 1	26
Anastrozole	Dr. Reddy's Laboratories	Phase 1	26
mRNA-1273.712	Moderna	Approved	0
Risperidone	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
Metformin + Glucophage	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
mRNA-0184	Moderna	Phase 1	0
Divalproex Sodium	Dr. Reddy's Laboratories	Phase 1	26
Sirolimus	Dr. Reddy's Laboratories	Phase 1	26
Glimepiride	Dr. Reddy's Laboratories	Phase 1	26
Ziprasidone Hydrochloride	Dr. Reddy's Laboratories	Phase 1	26
Naproxen sodium	Dr. Reddy's Laboratories	Phase 1	26